Evidence map›Paper›PMID 38022190›Full record

ArticleCureus2023

Late-Onset Type 1 Diabetes Mellitus and Unexplained Subcutaneous Lesions.

Malik A Tunc, Karim Amireh, Kevin Brar, Ramyaprabha Bondalapati, Pedro Novo, Alexey Podcheko Md

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Malik A TuncInternal Medicine, American University of the Caribbean, Cupecoy, SXM.
Karim AmirehInternal Medicine, American University of the Caribbean, Cupecoy, SXM.
Kevin BrarInternal Medicine, American University of the Caribbean, Cupecoy, SXM.
Ramyaprabha BondalapatiInternal Medicine, American University of the Caribbean, Cupecoy, SXM.
Pedro NovoInternal Medicine, American University of the Caribbean, Cupecoy, SXM.
Alexey Podcheko MdInternal Medicine, American University of the Caribbean, Cupecoy, SXM.
American University of the Caribbean School of Medicine · SX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nodular fasciitis is considered a reactive lesion of connective tissue originating from the proliferation of fibroblasts and myofibroblasts. Nodular fasciitis preponderantly localizes within the higher extremities, trunk, head, and neck. We are presenting a report on the case of a 38-year-old Navy pilot who developed nodular lesions in the area of the sternum and upper back and was diagnosed concomitantly with insulin-dependent diabetes mellitus (type 1 diabetes). The patient was treated for diabetic ketoacidosis using intensive insulin therapy protocol, and the nodules were surgically excised. He was discharged from the hospital four weeks later. In our presentation, we intend to highlight the essential characteristics of this rare lesion through a review of the literature and to identify an attainable link between the development of type 1 diabetes and nodular fasciitis.

Indexed as

diabetesinsulin autoimmune syndromenodular fasciitissubcutaneous nodulesystemic inflammatory and autoimmune diseasetype 1 diabetes mellitus (t1dm)

Identifiers

PMID38022190
PMCPMC10646697
OpenAlexW4387667684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.